Projects per year
Fingerprint Dive into the research topics where Ralph A Defronzo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Insulin
Medicine & Life Sciences
Glucose
Medicine & Life Sciences
Type 2 Diabetes Mellitus
Medicine & Life Sciences
Insulin Resistance
Medicine & Life Sciences
pioglitazone
Medicine & Life Sciences
Glucose Intolerance
Medicine & Life Sciences
Fasting
Medicine & Life Sciences
Hyperglycemia
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1978 2020
Discovery of Functional Variants in Type 2 Diabetes Genes in Mexican Americans
Duggirala, R., Abboud, H. E., Thameem, F., Blangero, J. C., Defronzo, R. A. & Lehman, D. M.
9/20/09 → 4/30/20
Project: Research project
Type 2 Diabetes Mellitus
Genome-Wide Association Study
Genes
Population
Single Nucleotide Polymorphism
SGLT2 INHIBITION AND STIMULATIION OF ENDOGENOUS GLUCOSE PRODUCTION
Project: Research project
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production
Project: Research project
Womb to Tomb: Developmental Programming and Aging Interactions in Primates
Cox, L., Clarke, G. D., Lanford, R. E., Fox, P. T., Cox, L., Defronzo, R. A. & Clarke, G. D.
Project: Research project
Durability of Early Combination Therapy vs Conventional Therapy in New Onset T2DM
9/1/15 → 8/31/18
Project: Research project
Diabetes Complications
Secondary Prevention
Hyperglycemia
Therapeutics
Research Output 1967 2019
1
Citation
(Scopus)
A neural signature of metabolic syndrome
Kotkowski, E., Price, L. R., Franklin, C., Salazar, M., Woolsey, M., Defronzo, R. A., Blangero, J., Glahn, D. C. & Fox, P. T., Jan 1 2019, In : Human Brain Mapping.Research output: Contribution to journal › Article
Brain
Occipital Lobe
Caudate Nucleus
Genetic Structures
Temporal Lobe
50
Citations
(Scopus)
Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm – 2019 executive summary
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., Defronzo, R. A., Einhorn, D., Fonseca, V. A., Garber, J. R., Garvey, W. T., Grunberger, G., Handelsman, Y., Hirsch, I. B., Jellinger, P. S., McGill, J. B., Mechanick, J. I., Rosenblit, P. D. & Umpierrez, G. E., Jan 1 2019, In : Endocrine Practice. 25, 1, p. 69-100 32 p.Research output: Contribution to journal › Review article
Endocrinology
Type 2 Diabetes Mellitus
Consensus
Committee Membership
Randomized Controlled Trials
Exenatide modulates visual cortex responses
Binda, P., Eldor, R., Huerta, C., Adams, J., Lancaster, J., Fox, P. T., Del Prato, S., Defronzo, R. A., Abdul-ghani, M. A. & Daniele, G., Jan 1 2019, In : Diabetes/Metabolism Research and Reviews. e3167.Research output: Contribution to journal › Article
Open Access
Visual Cortex
Magnetic Resonance Imaging
Glucagon-Like Peptide 1
Food
Food Preferences
13
Citations
(Scopus)
Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls
Broad Genomics Platform, DiscovEHR Collaboration, CHARGE, LuCamp, ProDiGY, GoT2D, ESP, SIGMA-T2D, T2D-GENES & AMP-T2D-GENES, Jun 6 2019, In : Nature. 570, 7759, p. 71-76 6 p.Research output: Contribution to journal › Article
Open Access
Exome
Type 2 Diabetes Mellitus
Genes
Gene Knockout Techniques
Gene Frequency
1
Citation
(Scopus)
Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG
Alatrach, M., Agyin, C., Mehta, R., Adams, J., Defronzo, R. A. & Abdul-ghani, M. A., Jan 1 2019, In : The Journal of clinical endocrinology and metabolism. 104, 1, p. 163-171 9 p.Research output: Contribution to journal › Article
Fasting
Insulin
Glucose
Clamping devices
Glucose Clamp Technique
Press/Media
Finally, a pill that could fix the root cause of diabetes
1/13/20
1 item of Media coverage
Press/Media: Press / Media
New Approved Complete Diabetes Regimen in One Tablet
11/9/19
1 item of Media coverage
Press/Media: Press / Media
Poxel Highlights Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
9/23/19 → 9/30/19
3 items of Media coverage
Press/Media: Press / Media
Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th annual meeting of the European Association for the Study of Diabetes
9/24/19
1 item of Media coverage
Press/Media: Press / Media
Potential Therapeutic Efficacy of Imeglimin in Targeting Mitochondrial Bioenergetics in T2D
9/19/19 → 9/21/19
2 items of Media coverage
Press/Media: Press / Media